30 April 2017
News and Views
Links and Services
The latest issue of Alimentary Pharmacology & Therapeutics reviews the response to therapy for inflammatory bowel disease-associated pyoderma gangrenosum in the biologic era.
Pyoderma gangrenosum in inflammatory bowel disease is uncommon and therapeutically challenging. <
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors